Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Articles|January 27, 2022
Daily OTC Pearl: Probiotic Pearls Women’s
Author(s)Saro Arakelians, PharmD
Probiotic Pearls Women’s helps support digestive and immune health.
Advertisement
OTC/Lifestyle Pearl of the Day: Probiotic Pearls Women’s
Indication: Probiotic Pearls Women’s helps support digestive and vaginal health with active cultures of lactobacilli.
Insight:
- Probiotic Pearls support immune health and protect against occasional bloating, constipation, and digestive discomfort.
- Active ingredients includes a proprietary probiotic blend providing 1 billion CFU howaru lactobacillus acidophilus NCFM, L. rhamnosus Lr-32, L. plantarum Lp-115.
- Other ingredients: Palm oil, fish gelatin, glycerin, soy lecithin, and pectin.
- Directions: Adults swallow 1 softgel daily. May be taken with or without food. Do not chew or crush.
Source:
Advertisement
Related to this article
Christie Ballantyne, MD, says high extension enrollment and a single 20-mg daily dose are encouraging signs for patient adherence to oral enlicitide.
An ASRA-recognized quality improvement project draws attention to injectate reproducibility, offering a starting point for examining medication preparation and pharmacists’ role in safer pain procedures.
A meta-analysis presented at IDWeek 2026 found responses were stronger after chemotherapy but waned within a year, supporting a 2-dose strategy.
How should a factor XIa inhibitor be incorporated into secondary stroke prevention?
Inconsistent state immunization laws complicate pharmacy operations and limit patient access.
Pharmacists can strengthen opioid safety through individualized counseling, overdose prevention, and coordinated follow-up that keeps patients involved in treatment decisions.
OCEANIC-STROKE supports a potential additional antithrombotic approach for select patients after noncardioembolic stroke or high-risk TIA.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Reportedly Shelves Commissioner's National Priority Voucher Program
2
Belantamab Mafodotin Moves Into Lenalidomide-Refractory Myeloma in Updated NCCN Guidelines
3
Inside the OCEANIC-STROKE Trial and What Asundexian Means for the Future of Stroke Prevention
4
Glucose Monitoring: Timing Makes Every Reading Count
5